{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:43:41Z","timestamp":1792511021595,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00520-025-09190-6","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T02:30:54Z","timestamp":1738549854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Patient-reported strategies for prevention and treatment of chemotherapy-induced peripheral neuropathy"],"prefix":"10.1007","volume":"33","author":[{"given":"Daniel L.","family":"Hertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Tanay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Tofthagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Paolo","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine E.","family":"Sheffield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Nekhlyudov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Grech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Von Ah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Ruddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam B.","family":"Lustberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"issue":"6","key":"9190_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3322\/caac.21204","volume":"63","author":"SB Park","year":"2013","unstructured":"Park SB, Goldstein D, Krishnan AV et al (2013) Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 63(6):419\u2013437","journal-title":"CA Cancer J Clin"},{"key":"9190_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejon.2018.09.003","volume":"36","author":"CW Chan","year":"2018","unstructured":"Chan CW, Cheng H, Au SK et al (2018) Living with chemotherapy-induced peripheral neuropathy: uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors. Eur J Oncol Nurs 36:135\u2013141","journal-title":"Eur J Oncol Nurs"},{"issue":"6","key":"9190_CR3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ana.24951","volume":"81","author":"NP Staff","year":"2017","unstructured":"Staff NP, Grisold A, Grisold W et al (2017) Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol 81(6):772\u2013781","journal-title":"Ann Neurol"},{"issue":"1","key":"9190_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10549-017-4230-8","volume":"164","author":"SM Monfort","year":"2017","unstructured":"Monfort SM, Pan X, Patrick R et al (2017) Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients. Breast Cancer Res Treat 164(1):69\u201377","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"9190_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/SPC.0000000000000684","volume":"18","author":"DL Hertz","year":"2024","unstructured":"Hertz DL (2024) Incidence, description, predictors, and consequences of persistent taxane-induced peripheral neuropathy. Curr Opin Support Palliat Care 18(1):30\u201338. https:\/\/doi.org\/10.1097\/SPC.0000000000000684","journal-title":"Curr Opin Support Palliat Care"},{"issue":"28","key":"9190_CR6","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","volume":"38","author":"CL Loprinzi","year":"2020","unstructured":"Loprinzi CL, Lacchetti C, Bleeker J et al (2020) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: asco guideline update. J Clin Oncol 38(28):3325\u20133348","journal-title":"J Clin Oncol"},{"issue":"10","key":"9190_CR7","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","volume":"31","author":"B Jordan","year":"2020","unstructured":"Jordan B, Margulies A, Cardoso F et al (2020) Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO\u2013EONS\u2013EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol 31(10):1306\u20131319","journal-title":"Ann Oncol"},{"issue":"1","key":"9190_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00520-00023-08209-00520","volume":"32","author":"DL Hertz","year":"2023","unstructured":"Hertz DL, Tofthagen C, Rossi E et al (2023) Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy. Support Care Cancer 32(1):48. https:\/\/doi.org\/10.1007\/s00520-00023-08209-00520","journal-title":"Support Care Cancer"},{"issue":"1","key":"9190_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10549-10016-13977-10547","volume":"160","author":"S Tsuyuki","year":"2016","unstructured":"Tsuyuki S, Senda N, Kanng Y et al (2016) Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group. Breast Cancer Res Treat 160(1):61\u201367. https:\/\/doi.org\/10.1007\/s10549-10016-13977-10547","journal-title":"Breast Cancer Res Treat"},{"key":"9190_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.breast.2019.1012.1011","volume":"49","author":"Y Kanbayashi","year":"2020","unstructured":"Kanbayashi Y, Sakaguchi K, Ishikawa T et al (2020) Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial. Breast 49:219\u2013224. https:\/\/doi.org\/10.1016\/j.breast.2019.1012.1011","journal-title":"Breast"},{"key":"9190_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3389\/fonc.2016.00274.eCollection02016","volume":"6","author":"R Sundar","year":"2016","unstructured":"Sundar R, Bandla A, Tan SS et al (2016) Limb hypothermia for preventing paclitaxel-induced peripheral neuropathy in breast cancer patients: a pilot study. Front Oncol 6:274. https:\/\/doi.org\/10.3389\/fonc.2016.00274.eCollection02016","journal-title":"Front Oncol"},{"key":"9190_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.breast.2019.1009.1011","volume":"48","author":"KJ Ruddy","year":"2019","unstructured":"Ruddy KJ, Le-Rademacher J, Lacouture ME et al (2019) Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial. Breast 48:89\u201397. https:\/\/doi.org\/10.1016\/j.breast.2019.1009.1011","journal-title":"Breast"},{"issue":"1","key":"9190_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.annonc.2019.1009.1006","volume":"31","author":"AJM Beijers","year":"2020","unstructured":"Beijers AJM, Bonhof CS, Mols F et al (2020) Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy. Ann Oncol 31(1):131\u2013136. https:\/\/doi.org\/10.1016\/j.annonc.2019.1009.1006","journal-title":"Ann Oncol"},{"key":"9190_CR14","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/jamainternmed.2024.2354","volume":"184","author":"F Streckmann","year":"2024","unstructured":"Streckmann F, Elter T, Lehmann HC, Baurecht H, Nazarenus T, Oschwald V, Koliamitra C, Otten S, Draube A, Heinen P, Steinmetz T, Hallek M, Leitzmann M, Bloch W, Balke M (2024) Preventive effect of neuromuscular training on chemotherapy-induced neuropathy: A randomized clinical trial JAMA. Intern Med 184:1046\u20131053. https:\/\/doi.org\/10.1001\/jamainternmed.2024.2354","journal-title":"Intern Med"},{"issue":"1","key":"9190_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/14737175.14732022.12018300","volume":"22","author":"SB Park","year":"2022","unstructured":"Park SB, Tamburin S, Schenone A et al (2022) Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion. Expert Rev Neurother 22(1):65\u201376. https:\/\/doi.org\/10.1080\/14737175.14732022.12018300","journal-title":"Expert Rev Neurother"},{"key":"9190_CR16","doi-asserted-by":"publisher","unstructured":"Sturgeon KM, Kok DE, Kleckner IR et al (2023) Updated systematic review of the effects of exercise on understudied health outcomes in cancer survivors. Cancer Med 12(24):22278\u201322292. https:\/\/doi.org\/10.21002\/cam22274.26753","DOI":"10.21002\/cam22274.26753"},{"key":"9190_CR17","doi-asserted-by":"publisher","unstructured":"de Boer AG, Tamminga SJ, Boschman JS et al (2024) Non-medical interventions to enhance return to work for people with cancer. Cochrane Database Syst Rev 3(3):CD007569. https:\/\/doi.org\/10.1002\/14651858.CD14007569.pub14651854","DOI":"10.1002\/14651858.CD14007569.pub14651854"},{"key":"9190_CR18","doi-asserted-by":"crossref","unstructured":"Turner RR, Steed L, Quirk H et al (2018) Interventions for promoting habitual exercise in people living with and beyond cancer. Cochrane Database Syst Rev 9(9):CD010192. doi: 010110.011002\/14651858.CD14010192.pub14651853","DOI":"10.1002\/14651858.CD010192.pub3"},{"key":"9190_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_349635","volume":"42","author":"AM Coletta","year":"2022","unstructured":"Coletta AM, Basen-Engquist KM, Schmitz KH (2022) Exercise across the cancer care continuum: why it matters, how to implement it, and motivating patients to move. Am Soc Clin Oncol Educ Book 42:1\u20137. https:\/\/doi.org\/10.1200\/EDBK_349635","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"9190_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00520-016-3404-y","volume":"25","author":"JM Schloss","year":"2017","unstructured":"Schloss JM, Colosimo M, Airey C et al (2017) A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Support Care Cancer 25(1):195\u2013204","journal-title":"Support Care Cancer"},{"issue":"10","key":"9190_CR21","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1200\/JCO.2013.52.0536","volume":"32","author":"CL Loprinzi","year":"2014","unstructured":"Loprinzi CL, Qin R, Dakhil SR et al (2014) Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB\/Alliance). J Clin Oncol 32(10):997\u20131005","journal-title":"J Clin Oncol"},{"issue":"20","key":"9190_CR22","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1200\/JCO.2012.44.8738","volume":"31","author":"DL Hershman","year":"2013","unstructured":"Hershman DL, Unger JM, Crew KD et al (2013) Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol 31(20):2627\u20132633","journal-title":"J Clin Oncol"},{"key":"9190_CR23","doi-asserted-by":"crossref","unstructured":"Ambrosone CB, Zirpoli GR, Hutson AD et al (2020) Dietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a cooperative group clinical trial (SWOG S0221). J Clin Oncol 38(8):804\u2013814. doi: 10.1200\/JCO.1219.01203","DOI":"10.1200\/JCO.19.01203"},{"key":"9190_CR24","doi-asserted-by":"publisher","unstructured":"Shakeel F, Fang F, Kidwell KM et al (2020) Comparison of eight screening tools to detect interactions between herbal supplements and oncology agents. J Oncol Pharm Pract 26(8):1843\u20131849. https:\/\/doi.org\/10.1177\/1078155220905009","DOI":"10.1177\/1078155220905009"},{"issue":"004362","key":"9190_CR25","first-page":"2023","volume":"27","author":"TW Chang","year":"2024","unstructured":"Chang TW, Yang FY, Liu YC et al (2024) Gabapentinoids for chemotherapy-induced peripheral neuropathy: systematic review and meta-analysis. BMJ Support Palliat Care 27(004362):2023\u2013004362","journal-title":"BMJ Support Palliat Care"},{"issue":"151685","key":"9190_CR26","doi-asserted-by":"publisher","first-page":"151685","DOI":"10.1016\/j.soncn.2024.151685","volume":"26","author":"G Kanzawa-Lee","year":"2024","unstructured":"Kanzawa-Lee G, Krauss JC, Knoerl R (2024) Exploring chemotherapy-induced peripheral neuropathy management practice patterns among oncology clinicians. Semin Oncol Nurs 26(151685):151685","journal-title":"Semin Oncol Nurs"},{"issue":"13","key":"9190_CR27","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2013.2813","volume":"309","author":"EM Smith","year":"2013","unstructured":"Smith EM, Pang H, Cirrincione C et al (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309(13):1359\u20131367","journal-title":"JAMA"},{"key":"9190_CR28","doi-asserted-by":"crossref","unstructured":"Dorsey SG, Kleckner IR, Barton D et al (2019) The national cancer institute clinical trials planning meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy. J Natl Cancer Inst 111(6):531\u2013537. doi: 510.1093\/jnci\/djz1011","DOI":"10.1093\/jnci\/djz011"},{"key":"9190_CR29","doi-asserted-by":"crossref","unstructured":"Knoerl R, Berry D, Meyerhardt JA et al (2022) Identifying participants\u2019 preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: an adaptive choice-based conjoint analysis. Support Care Cancer 30(12):9963\u20139973. doi: 9910.1007\/s00520-00022-07447-y","DOI":"10.1007\/s00520-022-07447-y"},{"issue":"9","key":"9190_CR30","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1007\/s00520-00019-05254-00526","volume":"28","author":"TM Salgado","year":"2020","unstructured":"Salgado TM, Quinn CS, Krumbach EK et al (2020) Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study. Support Care Cancer 28(9):4163\u20134172. https:\/\/doi.org\/10.1007\/s00520-00019-05254-00526","journal-title":"Support Care Cancer"},{"key":"9190_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.breast.2020.1002.1011","volume":"51","author":"TM Salgado","year":"2020","unstructured":"Salgado TM, Liu J, Reed HL et al (2020) Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: a pilot study. Breast 51:21\u201328. https:\/\/doi.org\/10.1016\/j.breast.2020.1002.1011","journal-title":"Breast"},{"key":"9190_CR32","doi-asserted-by":"crossref","unstructured":"Suarez-Lledo V, Alvarez-Galvez J (2021) Prevalence of health misinformation on social media: systematic review. J Med Internet Res 23(1):e17187. doi: 17110.12196\/17187","DOI":"10.2196\/17187"},{"issue":"2","key":"9190_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1158\/1055-9965.EPI-1120-1268","volume":"30","author":"H Arem","year":"2021","unstructured":"Arem H, Duan X, Ehlers DK et al (2021) Provider discussion about lifestyle by cancer history: a nationally representative survey. Cancer Epidemiol Biomarkers Prev 30(2):278\u2013285. https:\/\/doi.org\/10.1158\/1055-9965.EPI-1120-1268","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"9190_CR34","first-page":"283","volume":"33","author":"P Panesar","year":"2023","unstructured":"Panesar P, Mayo SJ (2023) \u201cTaking out the trash\u201d: strategies for preventing and managing fraudulent data in web-surveys. Can Oncol Nurs J 33(2):283\u2013284 (eCollection 2023 Spring)","journal-title":"Can Oncol Nurs J"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09190-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09190-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09190-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:42:27Z","timestamp":1739493747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09190-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["9190"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09190-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4888430\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by King's College London ethics committee (Reference:\u00a0HR-20\/21\u201325358).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript. MBL: Consulting for Eli Lilly, Gliead, Pfizer, AstraZeneca, Novartis.\u00a0Co-authors of this manuscript (e.g., M.B.L.) are editors of Journal of Supportive Care in Cancer.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}